Our analysis revealed that several inflammation-associated gene signatures are significantly enriched in patients exhibiting low USF2-NuRD complex scores alongside high Metab-GS scores (Figure 6, Red), suggesting that Metab-GS is associated with inflammatory tumor environment in bladder cancer. This evidence concerns the gene USF2 and urinary bladder cancer.